Healthcare -
Biotechnology - NASDAQ - US
$ 48.435
7.68 %
$ 3.15 B
Market Cap
-15.32
P/E
KYMR - OPERATING INCOME
Operating Income KYMR - Kymera Therapeutics, Inc.
-262 M
LAST VALUE
-27.38%
2 YEAR CAGR
-44.03%
5 YEAR CAGR
0.00%
10 YEAR CAGR